Reuters logo
BRIEF-Apricus Biosciences' unit and Takeda Pharmaceuticals sign license agreement
September 13, 2012 / 2:16 PM / 5 years ago

BRIEF-Apricus Biosciences' unit and Takeda Pharmaceuticals sign license agreement

Sept 13 (Reuters) - Apricus Biosciences Inc : * Biosciences’ wholly-owned subsidiary Nexmed (U.S.A.) and Takeda

Pharmaceuticals International GmbH sign exclusive license agreement to market

Vitaros in the United Kingdom * Says deal for undisclosed upfront payment, and milestone payments of up to

35 million euro.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below